A5050033074- Head and Neck Cancer Studies
- Lung Cancer Treatments and Mutations
- Cancer Diagnosis and Treatment
- Radiopharmaceutical Chemistry and Applications
- Esophageal Cancer Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Brain Metastases and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Medical and Biological Sciences
- Gastric Cancer Management and Outcomes
- BRCA gene mutations in cancer
- Head and Neck Surgical Oncology
- Lung Cancer Research Studies
- Metastasis and carcinoma case studies
- Reconstructive Surgery and Microvascular Techniques
- Esophageal and GI Pathology
Ministry of Health of the Russian Federation
2019-2024
Institute of Oncology NN Petrov
2021
Цель. оценка эффективности суперселективной химиоэмболизации сосудов опухоли в комбинации с химиотерапией и лучевой терапией у пациентов местно-распространенными злокачественными опухолями носоглотки. Материал методы. Проведено ретроспективное исследование проспективным наблюдением разделением на две группы: группе ХЭ+ХЛТ - первым этапом выполнялась суперселективная химиоэмболизация последующей сочетанной химиолучевой (ХЛТ), адъювантной (АХТ), ХЛТ АХТ. Оценка проводилась по бессобытийной...
Background. Radiation therapy for locally advanced nasopharyngeal carcinoma (NC) has a high incidence of fatal complications, which leads to absolute contraindications External Beam Therapy (EBRT). Chemoembolization tumor significantly reduces these risks and allows EBRT. The aim this study was assess response rate after chemoembolization Objective. To evaluate the in patients with cancer treated vessels external beam radiation combination chemotherapy. Methods. Prospective descriptive...
Introduction. In the 10th revision of International Classification Diseases (ICD-10), code for malignant neoplasms pharynx (mNN) is C11. These tumors are rare. The state statistics only presents information on morbidity. Data mortality due to mNN absent, they included into group other causes death. real assessment effectiveness antitumor management can be obtained from population Cancer Registry Database (pCR DB) Northwestern federal District Russian federation (NwfD Rf) developed by us....
Surgical resection is one of the standard treatment options for cancer larynx, regardless whether it combined with postoperative radiotherapy. Reconstruction defect often requires after removal tumor. The type surgery and reconstructive strategy (selecting recovery methods) depend on extent lesion number departments involved. This article presents a review literature larynx choice optimal surgical tactics.
Суперселективная химиоэмболизация (СХ) является на сегодняшний день перспективным методом лечения злокачественных новообразований органов головы и шеи. Описан клинический пример успешного комбинированного (СХ + системная химиотерапия) злокачественного новообразования носоглотки у пациента 40 лет с двухсторонним распространением T4N2-3M0, приводящего к снижению слуха двух сторон, существенному затруднению носового дыхания осложненного носовыми кровотечениями. Достигнуто значительное улучшение...
Three randomized phase III trials have now conclusively proven that exposure to a PD-1 inhibitor prolongs survival in recurrent/meta-static (R/M) HNSCC, and it is clear such agents should be used the management of all patients who do not contraindications their use. Two these showed antiPD-1 antibodies nivolumab pembrolizumab were superior investigators' choice chemotherapy second-line platinum-refractory R/M HNSCC. Recently, third trial, KEYNOTE-048, with was EXTREME regimen (cis- or...
The study objective – to analyze the treatment results and prognostic factors of survival in patients with locally advanced laryngeal cancer who received surgical chemoradiotherapy. Materials methods . retrospective included treated at N. Petrov National medical Research Center Oncology, Ministry Health Russia period from 2009 2018. were divided into 2 equal groups (74 each group) depending treatment: surgery postoperative radiation therapy combined chemotherapy (group 1) concurrent...
Objective. To analyze the results of treatment and prognostic factors general relapse-free survival in patients with locally advanced welldifferentiated thyroid cancer who received surgical treatment, radiation therapy, radioiodine therapy chemotherapy. Methods. T he retrospective study included a verified diagnosis well-differentiated at National Medical Research Centre Oncology n. a. N. Petrov (Saint Petersburg, Russia). The endpoints were overall disease-free survival. Results....
Aim. To analyze the results of treatment and prognostic factors survival in patients with cervical esophageal cancer (CEC) who received surgical treatment, chemoradiation therapy chemotherapy.
 Materials methods. The retrospective study included a verified diagnosis CEC treated at Petrov National Medicine Research Center Oncology from 2009 to 2018 divided into three groups: chemoradiotherapy chemotherapy. endpoints were overall (OS) relapse-free (RFS).
 Results. Ninety-seven study:...